IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 95 filers reported holding IGM BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,196 | +18.0% | 14,275 | +30.4% | 0.00% | – |
| Q2 2023 | $101,013 | -46.8% | 10,944 | -20.7% | 0.00% | – |
| Q1 2023 | $190,000 | +99376.4% | 13,800 | +23.0% | 0.00% | – |
| Q4 2022 | $191 | -99.9% | 11,215 | +2.0% | 0.00% | – |
| Q3 2022 | $250,000 | +38.9% | 10,992 | +10.4% | 0.00% | – |
| Q2 2022 | $180,000 | -42.3% | 9,961 | -14.4% | 0.00% | – |
| Q1 2022 | $312,000 | +41.8% | 11,632 | +54.7% | 0.00% | – |
| Q4 2021 | $220,000 | -49.7% | 7,517 | +13.0% | 0.00% | – |
| Q3 2021 | $437,000 | -12.1% | 6,655 | +11.4% | 0.00% | – |
| Q2 2021 | $497,000 | +47.0% | 5,974 | +35.4% | 0.00% | – |
| Q1 2021 | $338,000 | +7.3% | 4,413 | +23.5% | 0.00% | – |
| Q4 2020 | $315,000 | +59.1% | 3,573 | +35.0% | 0.00% | – |
| Q3 2020 | $198,000 | +13.1% | 2,646 | +10.5% | 0.00% | – |
| Q2 2020 | $175,000 | +96.6% | 2,394 | +50.8% | 0.00% | – |
| Q1 2020 | $89,000 | +43.5% | 1,588 | -1.7% | 0.00% | – |
| Q4 2019 | $62,000 | – | 1,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |